LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Aandelen Lijst・Microbot Medical Inc

Microbot Medical Inc

Gesloten

1.7 -3.41

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.7

Max

1.8

Belangrijke statistieken
By Trading Economics
Inkomsten	-207K -3.7M
Verkoop	105K 105K
EPS	-0.05
Winstmarge	-3,496.19
Werknemers	43
EBITDA	-192K -4.3M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+391.57% upside

Dividenden
By Dow Jones
Volgende Winsten	10 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-35M 112M
Vorige openingsprijs	5.11
Vorige sluitingsprijs	1.7

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

2.52 / 2.57 Steun & Weerstand

Microbot Medical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 mei 2026, 16:33 UTC

Winsten

Belangrijke Marktbewegers

Webull Shares Slide on 1Q Loss, Soaring Costs

22 mei 2026, 21:10 UTC

Winsten

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22 mei 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

22 mei 2026, 19:47 UTC

Winsten

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22 mei 2026, 19:17 UTC

Marktinformatie

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22 mei 2026, 19:10 UTC

Marktinformatie

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22 mei 2026, 18:54 UTC

Marktinformatie

Global Equities Roundup: Market Talk

22 mei 2026, 18:54 UTC

Marktinformatie

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22 mei 2026, 18:38 UTC

Marktinformatie

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22 mei 2026, 18:35 UTC

Acquisities, Fusies, Overnames

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22 mei 2026, 18:09 UTC

Marktinformatie

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mei 2026, 17:58 UTC

Marktinformatie

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

22 mei 2026, 17:54 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

22 mei 2026, 17:54 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

22 mei 2026, 17:54 UTC

Marktinformatie

Canada Minister May Be Distancing From Online-Streaming Order -- Market Talk

22 mei 2026, 17:03 UTC

Marktinformatie

Canada Spending Obligations on Streamers Is More Severe Beneath Surface -- Market Talk

22 mei 2026, 16:54 UTC

Marktinformatie

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 mei 2026, 16:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

22 mei 2026, 16:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

22 mei 2026, 16:20 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

22 mei 2026, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

22 mei 2026, 16:16 UTC

Marktinformatie

TSX Growth Driven Almost Entirely by Materials Sector -- Market Talk

22 mei 2026, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

22 mei 2026, 15:55 UTC

Marktinformatie

Trump Admin Grants Reinforce IBM's Quantum Computing Leadership -- Market Talk

22 mei 2026, 15:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

22 mei 2026, 15:42 UTC

Marktinformatie

Oil Continues as Leading Indicator for All Markets -- Market Talk

22 mei 2026, 15:35 UTC

Marktinformatie

Gas Prices May Limit Spread of Inflationary Pressures in Canada -- Market Talk

Peer Vergelijking

Prijswijziging

Microbot Medical Inc Prognose

Koersdoel

By TipRanks

391.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8.75 USD 391.57%

Hoogste 12 USD

Laagste 5.5 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Microbot Medical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Microbot Medical Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

2.52 / 2.57Steun & Weerstand

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.